297 related articles for article (PubMed ID: 29349669)
1. Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
Singh R; Mandhani A; Agrawal V; Garg M
Cancer Microenviron; 2018 Jun; 11(1):23-39. PubMed ID: 29349669
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.
Singh R; Singh UP; Agrawal V; Garg M
Mol Biol Rep; 2022 Aug; 49(8):7541-7556. PubMed ID: 35593896
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Liu B; Miyake H; Nishikawa M; Fujisawa M
Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expressions of EMT markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.
Tripathi K; Maurya N; Goel A; Singhai A; Garg M
Mol Cell Biochem; 2023 Jun; 478(6):1169-1190. PubMed ID: 36239855
[TBL] [Abstract][Full Text] [Related]
6. The study of miRNA-200c expression and epithelial-to-mesenchymal transition-related transcription factors in the primary bladder urothelial carcinoma.
Narwal A; Kumari K; Kaushal S; Seth A; Nayak B; Rustagi Y; Dinda AK
Urol Ann; 2023; 15(1):35-42. PubMed ID: 37006208
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
[TBL] [Abstract][Full Text] [Related]
9. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.
Paliwal P; Arora D; Mishra AK
Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777
[TBL] [Abstract][Full Text] [Related]
10. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
11. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer.
Zhao J; Dong D; Sun L; Zhang G; Sun L
Int Braz J Urol; 2014; 40(2):179-89. PubMed ID: 24856504
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
14. [Expression and roles of the epithelial mesenchymal transition markers E-cadherin and vimentin in hepatocellular carcinoma].
Li YM; Han KQ; Zheng L; Li J; Xu SC; Tian YW; Li HY; Pi HF; Qian P; Liang P
Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):279-84. PubMed ID: 24021790
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma.
Cho J; Ha SY; Kim SH; Sung HH; Kwon GY
Pathol Res Pract; 2018 Apr; 214(4):547-554. PubMed ID: 29572121
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
[TBL] [Abstract][Full Text] [Related]
17. Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
Ottley EC; Pell R; Brazier B; Hollidge J; Kartsonaki C; Browning L; O'Neill E; Kiltie AE
J Pathol Clin Res; 2020 Oct; 6(4):238-251. PubMed ID: 32374509
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.
Migita T; Ueda A; Ohishi T; Hatano M; Seimiya H; Horiguchi SI; Koga F; Shibasaki F
Lab Invest; 2017 May; 97(5):567-576. PubMed ID: 28240746
[TBL] [Abstract][Full Text] [Related]
19. Detection of Epithelial-Mesenchymal Transition Markers in High Grade Bladder Cancer and Special Variants of Urothelial Carcinoma.
Khalil H; Hammam OA; Kamel A
Asian Pac J Cancer Prev; 2022 Jun; 23(6):2079-2087. PubMed ID: 35763651
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
